No low-fat diet for the failing heart?

Circulation

Volumn 114, Issue 20, 2006, Pages 2092-2093

  Taegtmeyer, Heinrich ^a   Ballal, Kalpana ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ANTILIPEMIC AGENT; CARBOHYDRATE; FATTY ACID; GLUCOSE; GLYCOGEN; LACTIC ACID; NICOTINIC ACID DERIVATIVE; OXYGEN;

CONGESTIVE CARDIOMYOPATHY; EDITORIAL; ENERGY METABOLISM; FAT INTAKE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; HEART CONTRACTION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; LOW FAT DIET; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; CARDIAC OUTPUT, LOW; DIET, FAT-RESTRICTED; ENERGY METABOLISM; HUMANS; MYOCARDIUM; PYRAZINES; STROKE VOLUME;

EID: 33750979293     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.659235     Document Type: Editorial

References (20)

1. Evans CL. The effect of glucose on the gaseous metabolism of the isolated mammalian heart. J Physiol (Lond). 1914;47:407-418.
2. Starling EH, Visscher MB. The regulation of energy output of the heart. J Physiol (Lond). 1928;62:243-261.
3. Taegtmeyer H. Cardiac metabolism as a target for the treatment of heart failure. Circulation. 2004;110:894-896.
4. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem. 1998;273:29530- 29539.
5. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J. 1980;186:701-711.
6. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart: II: studies on fat, ketone and amino acid metabolism. Am J Med. 1954;16:504-515.
7. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000;278:H1345-H1351.
8. Goodwin GW, Taegtmeyer H. Improved energy homeostasis of the heart in the metabolic state of exercise. Am J Physiol Heart Circ Physiol. 2000;279:H1490-H1501.
9. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med. 1998;4:1269-1275.
10. Razeghi P, Young ME, Alcorn JL, Moravec CS, Frazier OH, Taegtmeyer H. Metabolic gene expression in fetal and failing human heart. Circulation. 2001;104:2923-2931.
11. Taegtmeyer H. Glycogen in the heart: an expanded view. J Mol Cell Cardiol. 2004;37:7-10.
12. Tuunanen H, Engblom E, Naum A, Nagren K, Hesse B, Airaksinen KEJ, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation. 2006;114:2130-2137.
13. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
14. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312:734-737.
15. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'Armiento J, Abel ED, Goldberg IJ. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem. 2006;281:8716-8723.
16. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 1999;48:1836-1841.
17. Boden G. Obesity, insulin resistance, type 2 diabetes and free fatty acids. Future Drugs-Expert Rev Endocrinol Metab. 2006;1:499-505.
18. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
19. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio heart study. Diabetes Care. 2002;25:1177-1184.
20. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol. 1994;19:57-116.